Minimal Offloading Dressing for the Treatment of Plantar Diabetes-related Foot Ulcers
MOD
Clinical Efficacy of a Novel Minimal Offloading Dressing for the Treatment of Plantar Diabetes-related Foot Ulcers: A Pilot Randomized Controlled Clinical Trial.
1 other identifier
interventional
40
1 country
1
Brief Summary
A monocentre randomized controlled parallel (1:1) clinical trial was performed with consecutively selected individuals with diabetes and active diabetes-related foot ulcers (DFU). Participants were randomly assigned to control or treatment groups. The experimental group received MOD treatments, and the control group received 15-mm felted foam treatments. All participants wore a removable ankle-high offloading device. Primary outcome measure was the 12-week healing rate. The time to healing was evaluated during a 12-week follow-up period. The secondary outcome measures included minor or major amputations related to the DFU during a follow-up period of 6 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2024
CompletedFirst Submitted
Initial submission to the registry
December 7, 2024
CompletedFirst Posted
Study publicly available on registry
December 11, 2024
CompletedDecember 17, 2025
December 1, 2024
9 months
December 7, 2024
December 9, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Healing rate
Healing was defined as intact skin at the foot-ulcer site with complete epithelialization and no drainage
12-weeks
Secondary Outcomes (3)
Minor amputation
6 months
Major amputation
6 months
Transfer lesions
12-weeks
Study Arms (2)
The experimental group received minimal offloading dressing (MOD) treatments
EXPERIMENTALThe MOD device was a monolayer device that can be applied directly to the participants skin via a non-irritative adhesive backing. The MOD was made of medium-density ethyl-vinyl acetate (40-45° Shore A hardness and 250-400-kg/cm2 density). The MOD is predesigned for three different locations: the first metatarsal head, central metatarsal heads, and fifth metatarsal. The MOD size ranged from size 35 to 48, which is measured according to the French system for each increase of 6.66 mm in length and 1.5 mm in width. All edges of the MOD were bevelled, and apertures were made to accommodate sites of plantar DFUs.
The control group received 15-mm felted foam treatments
ACTIVE COMPARATORThe felted padding used in the control group was made out of semi-compressed wool felt with an adhesive backing (Herbitas lab, 46134 Foios-Valencia, Spain). The padding thickness was 15 mm on the whole foot, and similar apertures to those used with the other offloading device were made to accommodate the sites of plantar ulceration.
Interventions
The felted padding used in the control group was made out of semi-compressed wool felt with an adhesive backing (Herbitas lab, 46134 Foios-Valencia, Spain). The padding thickness was 15 mm on the whole foot, and similar apertures to those used with the other offloading device were made to accommodate the sites of plantar ulceration.
Metatarsal minimal offloading dressings (MODs) are standard offloading devices that are gaining attention. MODs offload a specific ulcerated area and could reduce variability when applying the device onto the skin. MODs are new predesigned devices that do not require any further adaptation or clinician skills and can be directly applied to an ulcerated metatarsal head using a non-irritating adhesive.
Eligibility Criteria
You may qualify if:
- Type 1 or 2 diabetes mellitus.
- Age \>18 years,
- Plantar DFU with Texas classification IA or IIA.
- Glycaemic control confirmed by a haemoglobin A1c ≤ 10% (85.8 mmol/mol) in the previous 3 months.
You may not qualify if:
- Critical limb ischaemia as defined by the Trans-Atlantic Inter-Society Consensus II guidelines.
- Active DFU in the contralateral limb, major amputation (below or above the knee) of the contralateral limb.
- Soft tissue infection.
- Untreated diabetic foot osteomyelitis.
- Need for walking aids.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Diabetic Foot Unit. Universidad Complutense de Madrid
Madrid, Madrid, 28040, Spain
Related Publications (1)
Lazaro-Martinez JL, Garcia-Madrid M, Molines-Barroso RJ, Alvaro-Afonso FJ, Tardaguila-Garcia A, Lopez-Moral M. Clinical Efficacy of a Novel Minimal Offloading Dressing for the Treatment of Plantar Diabetes-Related Foot Ulcers: A Pilot Randomized Controlled Clinical Trial. Adv Skin Wound Care. 2026 Apr 1;39(3):152-158. doi: 10.1097/ASW.0000000000000413. Epub 2026 Feb 19.
PMID: 41718581DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. Dr.
Study Record Dates
First Submitted
December 7, 2024
First Posted
December 11, 2024
Study Start
December 1, 2023
Primary Completion
September 1, 2024
Study Completion
September 30, 2024
Last Updated
December 17, 2025
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share
IPD will be shared if asked from any institution